Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP500629.RAC1QI3lCzs-z_2d_7i0ILGjnepVHEb2D_lN62Bt6ooLM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP500629.RAC1QI3lCzs-z_2d_7i0ILGjnepVHEb2D_lN62Bt6ooLM130_assertion type Assertion NP500629.RAC1QI3lCzs-z_2d_7i0ILGjnepVHEb2D_lN62Bt6ooLM130_head.
- NP500629.RAC1QI3lCzs-z_2d_7i0ILGjnepVHEb2D_lN62Bt6ooLM130_assertion description "[Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor originally identified as part of the chimeric nucleophosmin-ALK protein in the t(2;5) chromosomal rearrangement associated with anaplastic large cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500629.RAC1QI3lCzs-z_2d_7i0ILGjnepVHEb2D_lN62Bt6ooLM130_provenance.
- NP500629.RAC1QI3lCzs-z_2d_7i0ILGjnepVHEb2D_lN62Bt6ooLM130_assertion evidence source_evidence_literature NP500629.RAC1QI3lCzs-z_2d_7i0ILGjnepVHEb2D_lN62Bt6ooLM130_provenance.
- NP500629.RAC1QI3lCzs-z_2d_7i0ILGjnepVHEb2D_lN62Bt6ooLM130_assertion SIO_000772 15972965 NP500629.RAC1QI3lCzs-z_2d_7i0ILGjnepVHEb2D_lN62Bt6ooLM130_provenance.
- NP500629.RAC1QI3lCzs-z_2d_7i0ILGjnepVHEb2D_lN62Bt6ooLM130_assertion wasDerivedFrom befree-2016 NP500629.RAC1QI3lCzs-z_2d_7i0ILGjnepVHEb2D_lN62Bt6ooLM130_provenance.
- NP500629.RAC1QI3lCzs-z_2d_7i0ILGjnepVHEb2D_lN62Bt6ooLM130_assertion wasGeneratedBy ECO_0000203 NP500629.RAC1QI3lCzs-z_2d_7i0ILGjnepVHEb2D_lN62Bt6ooLM130_provenance.